4

OWNERSHIP DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: September 15, 2023
Period of Report: September 15, 2023
Accession Number: 0001104659-23-101299

View Document ↗ View on SEC.gov ↗